The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care.

Smith, JR; Noble, MJ; Musgrave, S; et al.Murdoch, J; Price, GM; Barton, GR; Windley, J; Holland, R; Harrison, BD; Howe, A; Price, DB; Harvey, I; Wilson, AM
Date: 1 December 2012
Journal
Thorax
Publisher
British Thoracic Society
Publisher DOI
https://doi.org/10.1136/thoraxjnl-2012-202093
Related links
http://www.ncbi.nlm.nih.gov/pubmed/22941976
Abstract
Patients at risk of severe exacerbations contribute disproportionally to asthma mortality, morbidity and costs. We evaluated the effectiveness and costs of using 'asthma risk registers' for these patients in primary care.
View full metadata

Institute of Health Research

Collections of Former Colleges

Item views 0
Full item downloads 0